...
首页> 外文期刊>Journal of Molecular and Cellular Cardiology >Preconditioning protects endothelium by preventing ET-1-induced activation of NADPH oxidase and xanthine oxidase in post-ischemic heart.
【24h】

Preconditioning protects endothelium by preventing ET-1-induced activation of NADPH oxidase and xanthine oxidase in post-ischemic heart.

机译:预处理可通过防止ET-1诱导缺血后心脏中NADPH氧化酶和黄嘌呤氧化酶的活化来保护内皮。

获取原文
获取原文并翻译 | 示例

摘要

The hypothesis was tested that endothelin-1 (ET-1)-induced superoxide (O(2)(-)) generation mediates post-ischemic coronary endothelial injury, that ischemic preconditioning (IPC) affords endothelial protection by preventing post-ischemic ET-1, and thus O(2)(-), generation, and that opening of the mitochondrial ATP-dependent potassium channel (mK(ATP)) triggers the mechanism of IPC. Furthermore, the study was aimed at identifying the source of O(2)(-) mediating the endothelial injury. Langendorff-perfused guinea-pig hearts were subjected either to 30 min ischemia/35 min reperfusion (IR) or were preconditioned prior to IR with three cycles of either 5 min ischemia/5 min reperfusion or 5 min infusion/5 min washout of mK(ATP) opener diazoxide (0.5 mM). Coronary flow responses to acetylcholine (ACh) served as a measure of endothelium-dependent vascular function. Myocardial outflow of ET-1 and O(2)(-) and functional recoveries were followed during reperfusion. NADPH oxidase and xanthine oxidase (XO) activities were measured in cardiac homogenates. IR augmented ET-1 and O(2)(-) outflow and impaired ACh response. All these effects were attenuated or prevented by IPC and diazoxide, and 5-hydroxydecanoate (a selective mK(ATP) blocker) abolished the effects of IPC and diazoxide. Superoxide dismutase and tezosentan (a mixed ET-1-receptor antagonist) mimicked the effects of IPC, although they had no effect on the ET-1 generation. IR augmented also the activity of NADPH oxidase and XO. Apocynin treatment, that resulted in NADPH oxidase inhibition, prevented XO activation and O(2)(-) generation in IR hearts. The inhibition of XO, either by allopurinol or feeding the animals with tungsten-enriched chow, prevented post-ischemic O(2)(-) generation, although these interventions had no effect on the NADPH activity. In addition, the post-ischemic activation of NADPH oxidase and XO, and O(2)(-) generation were prevented by IPC, tezosentan, thenoyltrifluoroacetone (mitochondrial complex II inhibitor), and tempol (cell-membrane permeable O(2)(-) scavenger). In guinea-pig heart: (i) ET-1-induced O(2)(-) generation mediates post-ischemic endothelial dysfunction; (ii) IPC and diazoxide afford endothelial protection by attenuating the ET-1, and thus O(2)(-) generation, and the mK(ATP) opening triggers the protection; (iii) the NADPH oxidase maintains the activity of XO, and the XO-derived O(2)(-) mediates the endothelial injury, and (iv) ET-1 and O(2)(-) (probably of mitochondrial origin) are upstream activators of the NADPH oxidase-XO cascade, and IPC prevents the cascade activation and the endothelial dysfunction by preventing the ET-1 generation.
机译:测试了假设,即内皮素1(ET-1)诱导的超氧化物(O(2)(-))产生介导缺血性冠状动脉内皮损伤,即缺血预处理(IPC)通过防止缺血后ET-提供了内皮保护。 1,因此O(2)(-)的生成和线粒体ATP依赖性钾通道(mK(ATP))的打开触发了IPC的机制。此外,该研究旨在确定O(2)(-)介导内皮损伤的来源。对Langendorff灌注的豚鼠心脏进行30分钟局部缺血/ 35分钟再灌注(IR)或在IR之前进行预处理,以三个周期进行,即5分钟局部缺血/ 5分钟再灌注或5分钟灌注5分钟/ mK冲洗( ATP)开放剂二氮嗪(0.5 mM)。冠状动脉对乙酰胆碱(ACh)的血流反应可作为衡量内皮依赖性血管功能的指标。 ET-1和O(2)(-)的心肌流出和功能恢复期间再灌注。在心脏匀浆中测量NADPH氧化酶和黄嘌呤氧化酶(XO)的活性。红外增强ET-1和O(2)(-)流出并损害ACh反应。 IPC和二氮嗪可减弱或阻止所有这些作用,5-羟基癸酸酯(一种选择性的mK(ATP)阻断剂)废除了IPC和二氮嗪的作用。超氧化物歧化酶和替佐生坦(一种混合的ET-1受体拮抗剂)模仿了IPC的作用,尽管它们对ET-1的产生没有影响。 IR还增强了NADPH氧化酶和XO的活性。 Apocynin治疗,导致NADPH氧化酶抑制,阻止了XO激活和IR心中的O(2)(-)生成。 XO的抑制作用,无论是别嘌醇还是用富含钨的食物喂养动物,都可以防止缺血后O(2)(-)的产生,尽管这些干预措施对NADPH活性没有影响。此外,IPC,替佐生,壬基三氟丙酮(线粒体复合物II抑制剂)和tempol(细胞膜可渗透性O(2)( -)清道夫)。在豚鼠心脏中:(i)ET-1诱导的O(2)(-)生成介导缺血后内皮功能障碍; (ii)IPC和二氮嗪通过减弱ET-1提供内皮保护,从而产生O(2)(-),并且打开mK(ATP)会触发保护作用; (iii)NADPH氧化酶维持XO的活性,并且XO衍生的O(2)(-)介导内皮损伤,以及(iv)ET-1和O(2)(-)(可能是线粒体起源)它们是NADPH氧化酶XO级联反应的上游激活剂,而IPC通过阻止ET-1生成来防止级联反应激活和内皮功能障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号